First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Swedish Medtech söker ekonom/jurist